Funding
Funding not disclosed
Founders
Product
Problem
Current high‑speed compute platforms for drug discovery and medical simulation rely on deterministic, linear heuristics that process large data volumes quickly but cannot reason about ambiguous, non‑linear biological interactions. This lack of “understanding” limits the usefulness of speed‑focused hardware in complex R&D workflows.
Solution
OmniHenos introduces a middleware layer that simulates quantum states to provide non‑linear logic on top of existing compute hardware. By inserting this layer between the processor and the application, the platform enables the system to explore multiple interaction pathways and resolve ambiguous biological scenarios. The middleware runs on‑site within the client’s secure infrastructure, allowing algorithms to be trained directly on proprietary datasets while preserving data sovereignty. Integration is designed to be transparent to existing pipelines, requiring no replacement of current hardware. Ongoing benchmarking with Tier‑1 institutional partners validates the approach in real R&D environments.
Target Audience
Primary customers are pharmaceutical and biotech R&D teams, as well as academic and corporate groups conducting medical simulation that require advanced computational reasoning over complex biological systems.
Features
- Simulated quantum‑state engine that adds non‑linear reasoning capabilities to conventional high‑speed processors
- On‑site deployment within the client’s secure environment to train models on proprietary data
- Transparent integration layer that interfaces with existing compute stacks without hardware replacement
- Optimized for drug discovery and medical simulation workloads that involve complex biological interactions
- Maintains full data sovereignty by keeping all training and inference operations within the customer’s infrastructure